2m 2m 2m 2m 2m 2m 2m
LANTERN PHARMA (LTRN)
NASDAQ
$3.84+$0.010 (+0.26%)
Price as of Jun 23, 2026 4:10 PM EDT- $49.5MMarket Cap
- 19.31%1-Year Change
- BiotechnologyIndustry
LANTERN PHARMA (LTRN)
$3.84+$0.010 (+0.26%)
LTRN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.83 | ||
Change | -$0.05 (-1.29%) | ||
Open | $3.76 | ||
High | $3.88 | ||
Low | $3.76 | ||
Previous Close | $3.88 | ||
Volume | 58,542 | ||
30-Day Average Volume | 210,781 | ||
1-Week Change | -2.05% | ||
1-Month Change | 9.43% | ||
1-Year Change | 19.31% | ||
3-Year Change | -25.20% | ||
5-Year Change | -74.45% | ||
Fundamentals | |||
Shares Outstanding | 12.8M | ||
Total Assets | $7.2M | ||
Market Cap | $49.5M | ||
Enterprise Value | $44.6M | ||
Period: QTR TTM FY | |||
Revenue | -$59,451.00 | ||
Net Income | -$3.4M | ||
Free Cash Flow | -$3.8M | ||
EBIT | -$3.4M | ||
EBITDA | -$3.4M | ||
Net Working Capital | $3.3M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | -750 | ||
P/B | N/A | ||
P/E | -13 | ||
PEG | -1 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue